Search

Your search keyword '"Cheng-Ta, Y."' showing total 2 results
Start Over Author "Cheng-Ta, Y."
2 results on '"Cheng-Ta, Y."'

1. LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722

Author

Mok, T.S.K., primary, Nakagawa, K., additional, Park, K., additional, Ohe, Y., additional, Girard, N., additional, Kim, H.R., additional, Wu, Y-L., additional, Gainor, J., additional, Lee, S-H., additional, Chiu, C-H., additional, Sang-We, K., additional, Cheng-Ta, Y., additional, Liang, W., additional, Wu, L., additional, Lin, M-C., additional, Samol, J., additional, Zhang, X., additional, Sylvester, J., additional, Li, S., additional, and Yang, J.C-H., additional

Published
2022
Full Text
View/download PDF

2. 578P Tyrosine kinase inhibitor treatment of elderly patients with epidermal growth factor receptor mutated advanced non-small cell lung cancer: A multi-institute retrospective study.

Author

Hung, L-J., Chang, J.W-C., Huang, C-Y., Fang, Y-F., Chang, C-F., Kuo, C-H.S., Hsu, P-C., Cheng-Ta, Y., and Wu, C-E.

Subjects
*EPIDERMAL growth factor receptors, *NON-small-cell lung carcinoma, *ERLOTINIB, *PROTEIN-tyrosine kinase inhibitors, *OLDER patients, *RETROSPECTIVE studies
Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results